Partnerships & Procurement

Strategic Public-Private Engagements for Healthcare Transformation

Overview

CARE9 Global partners with Ministries of Health, Development Finance Institutions (DFIs), donor programs, sovereign funds, and institutional buyers to deliver not just products—but comprehensive healthcare platforms. Our partnerships enable governments to leapfrog into next-generation public health delivery through scalable, digitized, and financially sustainable infrastructure and services.

We are not a vendor. We are your strategic co-developer of tomorrow’s national healthcare architecture.

Our Partnership Model

CARE9’s partnership strategy encompasses five core pillars:

1. Public-Private Partnerships (PPPs)

Structuring long-term, risk-mitigated infrastructure and service models using BOOT (Build-Own-Operate-Transfer) and BOT (Build-Operate-Transfer) frameworks, performance-linked concessions, and blended capital stacks.

Key Benefits:

  • Capital stack design unlocking multilateral and private finance
  • Lifecycle service integration from construction through clinical operations
  • Full technology transfer and workforce development
  • Risk mitigation through performance-based contracts
  • Government maintains strategic oversight and public access

Model Flexibility:

  • BOOT for specialty hospitals, manufacturing plants, diagnostic centers, and digital platforms (10-30 year concessions)
  • BOT for provincial hospitals, diagnostic centers co-located in public facilities, and logistics infrastructure (5-15 year concessions)

2. Government Procurement Models

Transforming health commodity procurement through long-term agreements, local manufacturing, and essential medicines partnerships.

Strategic Components:

  • Long-Term Procurement Agreements (LTPAs): Multi-year supply commitments spanning 3-10 years with pre-negotiated pricing and flexible volume schedules
  • Import Substitution: Transitioning from full import dependence to co-developed domestic production capacity through contract manufacturing transitions
  • Essential Drug List (EDL) Optimization: Ensuring procurement aligns with clinical relevance and national disease priorities
  • Technology Integration: Modern workflows with vendor performance dashboards, stock status tracking, and AI-powered demand forecasting

3. Supply Chain Integration

Digitally-driven, audit-ready, and traceable healthcare supply chains from manufacturer to facility, ensuring:

  • CARE9 Verified® traceability platform with end-to-end visibility
  • 100% Stock Availability Promise with real-time reorder triggers
  • Interactive Dashboards for ministries and central procurement agencies
  • Decentralized Last-Mile Delivery supporting equity and rural access
  • Compliance Alignment with WHO, USFDA, EMA, and donor frameworks

4. Hospital Network Engagement

Enabling seamless, scalable healthcare operations across public and hybrid hospital networks through:

  • Pharmacy-as-a-Service (PaaS): Full pharmacy operations management with 25-30% cost reduction
  • CARE9 HIMS Deployment: Complete digital ecosystem for patient management, billing, and claims
  • Integrated Diagnostics: Seamless lab and imaging workflows with quality assurance
  • SLA-Based Performance: Guaranteed drug availability, lab turnaround times, and system uptime

5. Vendor & Manufacturer Partnerships

Building compliant, high-output ecosystems through:

  • Strategic Sourcing Partners: WHO-GMP, USFDA, EMA-approved manufacturers in Asia and Europe
  • Private-Label & White-Label Opportunities: Branded products and customized formulations
  • Regional Distribution Hubs: Operations across Africa, Europe, and Latin America
  • Co-Manufacturing & CDMO Services: Technology transfer and local manufacturing capacity

Regional Footprint

Africa

Ghana: 250-bed Indo-African Oncology Institute under CARE9-DIHOC PPP framework Zambia & Namibia: Oncology and diagnostics centers under BOOT discussions Kenya & Tanzania: Digital health PPPs for insurance claims and laboratory infrastructure DRC & Cameroon: BOT pilots for district hospital upgrade and modular diagnostic labs

Eastern Europe

Moldova, Greece, Balkans: CDMO manufacturing and diagnostics labs under co-funding with EU-linked institutions Public-Private Digital Partnerships: Hospital networks and health system digitization initiatives

Latin America

Brazil, Colombia, Peru: Institutional partnerships for oncology pharmaceuticals, digital health, and mobile diagnostic outreach Diagnostic Networks: Lab integration and imaging services across state health systems

Partnership Success Metrics

Our engagement model targets measurable outcomes:

  • Facility Uptime: >98% drug availability, >99.5% HIMS availability
  • Cost Efficiency: 20-35% total procurement savings vs. short-cycle procurement
  • Workforce Development: 500+ healthcare workers trained per facility
  • Patient Impact: 100,000+ patients screened annually per institute; 30-40% reduction in outbound medical travel
  • Financial Sustainability: Break-even operations by Year 3-5 post-launch

Capital Stack Architecture

CARE9 structures blended capital stacks that align all stakeholders:

  • DFI Debt (50-60%): IFC, AfDB, Proparco, DEG, BNDES, regional DFIs
  • Export Credit/ECA Finance (20-30%): EXIM Bank India, Euler Hermes, SACE
  • Sponsor Equity (15-20%): CARE9 + strategic partners and local co-investors
  • Donor Grants/Viability Gap Funding: Global Fund, GAVI, Gates Foundation, national budgets
  • Sovereign Participation: Land allocation, licensing support, long-term service contracts

Governance & Accountability

To ensure accountability and protect public interest, CARE9 implements:

  • Joint Steering Committees with Ministry of Health, CARE9, and DFI/Donor partners
  • Key Performance Indicators (KPIs) tied to uptime, patient volumes, and clinical quality
  • Transparent Service-Level Agreements (SLAs) with financial triggers
  • Annual audits by independent clinical and financial auditors
  • Knowledge transfer pathways to build public sector capacity

Why Choose CARE9 as Your Partnership Partner?

Proven Track Record: Operations across 15+ countries in Africa, Europe, and Latin America with measurable health outcomes

Integrated Expertise: Clinical, operational, financial, and regulatory excellence under one partner

Technology-Enabled: Proprietary platforms (CARE9 Verified®, CARE9 HIMS) ensuring transparency, traceability, and performance

Risk Mitigation: Structured models that protect government assets, reduce financial exposure, and ensure sustainability

Local Capacity Building: Comprehensive training and knowledge transfer ensuring local ownership and long-term success

Flexible Scaling: Modular engagement models supporting incremental implementation across hospital networks

Getting Started

Governments, DFIs, and institutional buyers interested in partnership discussions are invited to:

  1. Explore Use Cases: Review our regional deployments and sector examples
  2. Assess Fit: Evaluate CARE9’s model against your healthcare priorities
  3. Develop Framework: Co-design partnership structure, timelines, and capital requirements
  4. Mobilize Resources: Structure financing and multi-stakeholder engagement
  5. Execute & Scale: Launch flagship projects with rapid replication across networks

Contact Our Partnership Team

For discussions on public-private partnerships, procurement modernization, or supply chain integration:

Email: partnerships@care9global.com Phone: Available upon request Regional Offices: Accra (Ghana), Hyderabad (India), Barcelona (Spain), New York (USA)

CARE9 Global: Not a vendor. A partner in building sovereign, sustainable, and equitable healthcare systems.